Jennifer Jarrett
Directeur des opérations chez ARCUS BIOSCIENCES, INC.
Fortune : 4 M $ au 30/04/2024
Profil
Jennifer A.
Jarrett is currently an Independent Director at Syndax Pharmaceuticals, Inc., a Director at SMART Reading, a Director at LifeMine Therapeutics, Inc., an Independent Director at Zura Bio Ltd., and the Chief Operating Officer at Arcus Biosciences, Inc. In the past, Ms. Jarrett worked as a Director & MD-Health Care Investment Banking at Credit Suisse Group AG from 2000 to 2010, a Managing Director-Health Care Investment Banking at Citigroup, Inc. from 2010 to 2016, an Independent Director at Arena Pharmaceuticals, Inc. from 2017 to 2022, an Independent Director at Radius Health, Inc. in 2022, an Independent Director at Astellas Gene Therapies, Inc. from 2017 to 2020, the Chief Financial Officer at Medivation, Inc. in 2016, and an Associate at Donaldson, Lufkin & Jenrette International from 1998 to 2000.
Ms. Jarrett also served as the VP-Corporate Development & Capital Markets at Uber Technologies, Inc. from 2019 to 2020 and at Uber, Inc. from 2018 to 2019.
Ms. Jarrett completed her undergraduate degree at Dartmouth College in 1992 and earned an MBA from the Graduate School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARCUS BIOSCIENCES, INC.
0,24% | 27/03/2024 | 215 253 ( 0,24% ) | 3 M $ | 30/04/2024 |
| 08/03/2024 | 48 000 ( 0,06% ) | 987 360 $ | 30/04/2024 |
Postes actifs de Jennifer Jarrett
| Sociétés | Poste | Début |
|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 25/09/2018 |
| ARCUS BIOSCIENCES, INC. | Directeur des opérations | 01/10/2020 |
| ZURA BIO LIMITED | Directeur/Membre du Conseil | 01/03/2023 |
LifeMine Therapeutics, Inc.
 LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 13/10/2022 |
SMART Reading /Oregon/
 SMART Reading /Oregon/ Miscellaneous Commercial ServicesCommercial Services SMART Reading offers literacy support to children. It helps kids become confident readers by providing individual volunteer attention and new, take-home books. The company was founded in 1992 and is headquartered in Portland, OR. | Directeur/Membre du Conseil | - |
Anciens postes connus de Jennifer Jarrett
| Sociétés | Poste | Fin |
|---|---|---|
| RADIUS HEALTH, INC. | Directeur/Membre du Conseil | 15/08/2022 |
| ARENA PHARMACEUTICALS | Directeur/Membre du Conseil | 11/03/2022 |
| UBER TECHNOLOGIES, INC. | Corporate Officer/Principal | 01/09/2020 |
| AUDENTES THERAPEUTICS, INC. | Directeur/Membre du Conseil | 15/01/2020 |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Jennifer Jarrett
| Dartmouth College | Undergraduate Degree |
| Graduate School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Health Technology |
| CITIGROUP INC. | Finance |
| ARCUS BIOSCIENCES, INC. | Health Technology |
| UBER TECHNOLOGIES, INC. | Transportation |
| ZURA BIO LIMITED | Health Technology |
| Entreprise privées | 11 |
|---|---|
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Credit Suisse Group AG
 Credit Suisse Group AG Investment Banks/BrokersFinance Credit Suisse Group AG is a holding company, which engages in the provision of financial services. It operates through the following four divisions: Wealth Management, Investment Bank, Swiss Bank and Asset Management and four geographic regions: Switzerland, Europe, the Middle East and Africa (EMEA), Asia Pacific, and Americas. The Wealth Management division offers comprehensive wealth management and investment solutions, tailored financing, and advisory services to ultra-high-net-worth (UHNW) and high net-worth (HNW) individuals and external asset managers. The Investment Bank division offers a broad range of financial products and services focused on client-driven businesses and also supports Credit Suisse’s Wealth Management division and its clients. The Swiss Bank division offers comprehensive advice and a wide range of financial solutions to private, corporate, and institutional clients in Switzerland. The Asset Management division offers investment solutions and services globally to a broad range of clients, including pension funds, governments, foundations and endowments, corporations, and individuals. The company was founded by Alfred Escher on July 5, 1856 and is headquartered in Zurich, Switzerland. | Finance |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
| Donaldson, Lufkin & Jenrette International | Finance |
Uber, Inc.
 Uber, Inc. Specialty StoresRetail Trade UBER, Inc. retails outdoor sports products. The company was founded on February 2, 2007 and is headquartered in Fountain Valley, CA. | Retail Trade |
Consonance-HFW Acquisition Corp.
 Consonance-HFW Acquisition Corp. Financial ConglomeratesFinance Consonance-HFW Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisitions, share purchase, reorganization, or similar business combination. The company was founded by Gad Soffer and Kevin Harold Livingston on August 21, 2020 and is headquartered in Princeton, NJ. | Finance |
| Medivation, Inc. /Old/ | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
SMART Reading /Oregon/
SMART Reading /Oregon/ Miscellaneous Commercial ServicesCommercial Services SMART Reading offers literacy support to children. It helps kids become confident readers by providing individual volunteer attention and new, take-home books. The company was founded in 1992 and is headquartered in Portland, OR. | Commercial Services |
LifeMine Therapeutics, Inc.
LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Health Technology |
